Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de neuro-psiquiatria (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900755 |
Resumo: | This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS. |
id |
ABNEURO-1_b7ab88591ddc32522185b5506c755cc3 |
---|---|
oai_identifier_str |
oai:scielo:S0004-282X2015000900755 |
network_acronym_str |
ABNEURO-1 |
network_name_str |
Arquivos de neuro-psiquiatria (Online) |
repository_id_str |
|
spelling |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AISischemic strokethrombolytic therapyhypertensionsodium nitroprussitesafetyThis study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS.Academia Brasileira de Neurologia - ABNEURO2015-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900755Arquivos de Neuro-Psiquiatria v.73 n.9 2015reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282X20150104info:eu-repo/semantics/openAccessKoslyk,Jessyca L.Ducci,Renata D.Nóvak,Edison M.Zétola,Viviane F.Lange,Marcos C.eng2015-08-31T00:00:00Zoai:scielo:S0004-282X2015000900755Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2015-08-31T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse |
dc.title.none.fl_str_mv |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
title |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
spellingShingle |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS Koslyk,Jessyca L. ischemic stroke thrombolytic therapy hypertension sodium nitroprussite safety |
title_short |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
title_full |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
title_fullStr |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
title_full_unstemmed |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
title_sort |
Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS |
author |
Koslyk,Jessyca L. |
author_facet |
Koslyk,Jessyca L. Ducci,Renata D. Nóvak,Edison M. Zétola,Viviane F. Lange,Marcos C. |
author_role |
author |
author2 |
Ducci,Renata D. Nóvak,Edison M. Zétola,Viviane F. Lange,Marcos C. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Koslyk,Jessyca L. Ducci,Renata D. Nóvak,Edison M. Zétola,Viviane F. Lange,Marcos C. |
dc.subject.por.fl_str_mv |
ischemic stroke thrombolytic therapy hypertension sodium nitroprussite safety |
topic |
ischemic stroke thrombolytic therapy hypertension sodium nitroprussite safety |
description |
This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900755 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900755 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0004-282X20150104 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
dc.source.none.fl_str_mv |
Arquivos de Neuro-Psiquiatria v.73 n.9 2015 reponame:Arquivos de neuro-psiquiatria (Online) instname:Academia Brasileira de Neurologia instacron:ABNEURO |
instname_str |
Academia Brasileira de Neurologia |
instacron_str |
ABNEURO |
institution |
ABNEURO |
reponame_str |
Arquivos de neuro-psiquiatria (Online) |
collection |
Arquivos de neuro-psiquiatria (Online) |
repository.name.fl_str_mv |
Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia |
repository.mail.fl_str_mv |
||revista.arquivos@abneuro.org |
_version_ |
1754212778592174080 |